| 标题 |
Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:European journal of cancer (Oxford, England : 1990) 作者:Demidov L; Samoylenko I; Kharkevich G; Orlova K; Moiseenko V; et al 出版日期:2025/09/09 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)